DC Funds, LP — Q2 2025 13F-HR

← DC Funds, LP

Q2 2025 · 13F-HR

DC Funds, LPholdings as filed

Filed 2025-08-14 · accession 0001398344-25-015410

$2.2M

Reported value

Positions

2025-06-30

Period end

View analyzed profile →PRO

The Brief · DC Funds, LP · Q2 2025

AI · grounded in 13F

DC Funds, LP established three new positions to reach a total AUM of $2,152,935. The fund's largest move was a $913,500 investment in TCRX. It also added positions in HOWL for $642,121 and BRNS for $597,314.

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
89854M101	TCRX	TSCAN THERAPEUTICS INC	$913,500	42.4%	630,000	Common	SOLE
95075A107	HOWL	WEREWOLF THERAPEUTICS INC	$642,121	29.8%	589,102	Common	SOLE
91864C107	BRNS	BARINTHUS BIOTHERAPEUTICS PL	$597,314	27.7%	642,204	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.